Warning: members of the public are being contacted by people claiming to work for AXA Investment Managers UK Limited.  Find out more information and what to do by clicking here.

Corporate news

AXA IM hires new portfolio manager to join Healthcare team


AXA Investment Managers (AXA IM) today announces the appointment of Catherine Tennyson as Healthcare Portfolio Manager.

Based in London, Catherine will be a co-lead Portfolio Manager on the Healthcare equity range which comprises of AXA IM’s Health, Biotech, and Longevity strategies. She will work alongside Cinney Zhang and Chris Eccles both Healthcare Portfolio Managers at AXA IM. She reports to Tom Riley, Head of Global Thematic Strategies.

Catherine joins AXA IM from Point 72 Asset Management where she was a healthcare research analyst, and studied medicine at Cambridge University.

Commenting on Catherine’s appointment, Tom Riley, Head of Global Thematic Strategies at AXA IM Equity said: “I am delighted to welcome Catherine to our team. Her robust experience in healthcare equities will help AXA IM strengthen and develop its thematics capabilities. Her medical background, alongside her responsible investing experience, will be instrumental in the management and continued development of our Healthcare related strategies and our broader global equity capabilities.”

AXA IM manages c. €54 billion 1 of assets under management in equity. The equity investment team is fundamentally driven, active in approach, and manages a range of ESG-integrated qualitative and quantitative investment solutions (including Global, Regional & Country, Thematics, Sustainable & Impact, Exchange Traded Funds).

Capital at risk. The value of investments, and any income from them, may fall as well as rise and investors may get back less than they originally invested.

  • QXMgb2YgdGhlIGVuZCBvZiBEZWNlbWJlciAyMDIzLCBpbmNsdWRpbmcgSlYu

Notes to editors

Biography

Catherine Tennyson joined AXA IM as Portfolio Manager on 29 February 2024. She joins AXA IM from Point 72 Asset Management where she was a healthcare Research Analyst. She began her career in EU MedTech research roles at Citi and Bank of America Merrill Lynch before joining Impax Asset Management in 2021 where she was Global Healthcare Analyst. Catherine holds a bachelor’s degree in medicine from Cambridge University. 


About AXA Investment Managers

AXA Investment Managers (AXA IM) is a leading global asset manager offering a diverse range of global investment opportunities in both alternative and traditional asset classes. Through our products we aim to diversify and grow portfolios, while delivering long-term investment performance and value for clients.

AXA IM manages approximately €844 billion in assets, of which €480 billion are categorised ESG-integrated, sustainable or impact as at the end of December 2023. We are committed to reaching net zero greenhouse gas emissions by 2050 across all eligible assets, and to integrating ESG principles across our business, from stock selection to our corporate actions and culture.

Part of the AXA Group, a worldwide leader in insurance and asset management, AXA IM employed over 2,800 employees and operates from 23 offices in 18 countries globally at end of December 2023.

Visit our website: www.axa-im.com

Follow us on X (formerly Twitter): @AXAIM

Follow us on LinkedIn

Visit our media centre: www.axa-im.com/media-centre

This press release should not be regarded as an offer, solicitation, invitation, or recommendation to subscribe for any investment service or product and is provided for information purposes only. No financial decisions should be made on the basis of information provided.

Due to its simplification, this document is partial and opinions, estimates and forecasts herein are subjective and subject to change without notice. There is no guarantee forecasts made will come to pass. Data, figures, declarations, analysis, predictions and other information in this document is provided based on our state of knowledge at the time of creation of this document. Whilst every care is taken, no representation or warranty (including liability towards third parties), express or implied, is made as to the accuracy, reliability or completeness of the information contained herein. Reliance upon information in this material is at the sole discretion of the recipient. This material does not contain sufficient information to support an investment decision.

Before making an investment, investors should read the relevant Prospectus and the Key Investor Information Document / scheme documents, which provide full product details including investment charges and risks. The information contained herein is not a substitute for those documents or for professional external advice.

The products or strategies discussed in this document may not be registered nor available in your jurisdiction. Please check the countries of registration with the asset manager, or on the web site https://www.axa-im.com/en/registration-map, where a fund registration map is available. In particular units of the funds may not be offered, sold or delivered to U.S. Persons within the meaning of Regulation S of the U.S. Securities Act of 1933. The tax treatment relating to the holding, acquisition or disposal of shares or units in the fund depends on each investor’s tax status or treatment and may be subject to change. Any potential investor is strongly encouraged to seek advice from its own tax advisers.

For more information on sustainability-related aspects please visit https://www.axa-im.com/what-is-sfdr

Issued in the UK by AXA Investment Managers UK Limited, which is authorised and regulated by the Financial Conduct Authority in the UK. Registered in England and Wales No: 01431068. Registered Office: 22 Bishopsgate London EC2N 4BQ

In other jurisdictions, this document is issued by AXA Investment Managers SA’s affiliates in those countries.            

    Disclaimer

    This press release should not be regarded as an offer, solicitation, invitation, or recommendation to subscribe for any investment service or product and is provided for information purposes only. No financial decisions should be made on the basis of information provided.

    Due to its simplification, this document is partial and opinions, estimates and forecasts herein are subjective and subject to change without notice. There is no guarantee forecasts made will come to pass. Data, figures, declarations, analysis, predictions and other information in this document is provided based on our state of knowledge at the time of creation of this document. Whilst every care is taken, no representation or warranty (including liability towards third parties), express or implied, is made as to the accuracy, reliability or completeness of the information contained herein. Reliance upon information in this material is at the sole discretion of the recipient. This material does not contain sufficient information to support an investment decision.

    Before making an investment, investors should read the relevant Prospectus and the Key Investor Information Document / scheme documents, which provide full product details including investment charges and risks. The information contained herein is not a substitute for those documents or for professional external advice.

    The products or strategies discussed in this document may not be registered nor available in your jurisdiction. Please check the countries of registration with the asset manager, or on the web site https://www.axa-im.com/en/registration-map, where a fund registration map is available. In particular units of the funds may not be offered, sold or delivered to U.S. Persons within the meaning of Regulation S of the U.S. Securities Act of 1933. The tax treatment relating to the holding, acquisition or disposal of shares or units in the fund depends on each investor’s tax status or treatment and may be subject to change. Any potential investor is strongly encouraged to seek advice from its own tax advisers.

    For more information on sustainability-related aspects please visit https://www.axa-im.com/what-is-sfdr

    Issued in the UK by AXA Investment Managers UK Limited, which is authorised and regulated by the Financial Conduct Authority in the UK. Registered in England and Wales No: 01431068. Registered Office: 22 Bishopsgate London EC2N 4BQ

    In other jurisdictions, this document is issued by AXA Investment Managers SA’s affiliates in those countries

    Risk Warning

    The value of investments, and the income from them, can fall as well as rise and investors may not get back the amount originally invested.